ALLIANCEBERNSTEIN L.P. - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$301,427
-55.6%
88,655
-4.1%
0.00%
Q2 2023$679,463
-29.1%
92,4440.0%0.00%
Q1 2023$957,720
-54.7%
92,444
-48.4%
0.00%
-100.0%
Q4 2022$2,113,955
-32.4%
178,997
+20.2%
0.00%
-50.0%
Q3 2022$3,127,000
+1.8%
148,954
+50.5%
0.00%
+100.0%
Q2 2022$3,071,000
-46.2%
98,946
-28.8%
0.00%
-50.0%
Q1 2022$5,705,000
+33.4%
138,950
+41.2%
0.00%0.0%
Q4 2021$4,276,000
-45.5%
98,372
-37.2%
0.00%
-33.3%
Q3 2021$7,839,000
-9.9%
156,555
+13.4%
0.00%0.0%
Q2 2021$8,698,000
-33.9%
138,090
-2.5%
0.00%
-50.0%
Q1 2021$13,161,000
+4.0%
141,650
+0.3%
0.01%0.0%
Q4 2020$12,654,000
-14.1%
141,226
-0.9%
0.01%
-25.0%
Q3 2020$14,723,000
+52.7%
142,490
+16.9%
0.01%
+33.3%
Q2 2020$9,639,000
+48.8%
121,893
+8.8%
0.01%
+20.0%
Q1 2020$6,480,000
+1.3%
112,003
-5.5%
0.01%
+25.0%
Q4 2019$6,394,000
+3.4%
118,521
+0.2%
0.00%0.0%
Q3 2019$6,186,000
-2.5%
118,321
-9.9%
0.00%0.0%
Q2 2019$6,342,000
+11.2%
131,271
+16.3%
0.00%0.0%
Q1 2019$5,702,000
-11.4%
112,871
+4.0%
0.00%
-20.0%
Q4 2018$6,434,000
-22.9%
108,532
-14.4%
0.01%0.0%
Q3 2018$8,346,000
+57.6%
126,780
+20.9%
0.01%
+25.0%
Q2 2018$5,295,000
+15.0%
104,872
+19.9%
0.00%
+33.3%
Q1 2018$4,605,000
+13.3%
87,4720.0%0.00%0.0%
Q4 2017$4,065,000
+8.8%
87,472
-5.3%
0.00%0.0%
Q3 2017$3,736,000
+16.2%
92,372
-2.6%
0.00%
+50.0%
Q2 2017$3,214,000
+123.5%
94,792
+91.5%
0.00%
+100.0%
Q1 2017$1,438,000
-11.6%
49,5120.0%0.00%0.0%
Q4 2016$1,626,000
+4.2%
49,5120.0%0.00%0.0%
Q3 2016$1,561,000
-11.6%
49,512
-21.2%
0.00%
-50.0%
Q2 2016$1,766,000
-11.9%
62,812
+13.9%
0.00%0.0%
Q1 2016$2,005,000
+11.3%
55,152
+22.4%
0.00%0.0%
Q4 2015$1,802,000
+41.1%
45,042
+0.5%
0.00%
+100.0%
Q3 2015$1,277,000
-13.7%
44,812
-0.2%
0.00%0.0%
Q2 2015$1,479,000
+21.9%
44,882
+6.4%
0.00%0.0%
Q1 2015$1,213,000
+0.3%
42,182
-5.0%
0.00%0.0%
Q4 2014$1,209,000
+27.8%
44,3820.0%0.00%0.0%
Q3 2014$946,000
-5.1%
44,3820.0%0.00%0.0%
Q2 2014$997,000
-11.1%
44,382
-0.0%
0.00%0.0%
Q1 2014$1,122,000
+2.4%
44,392
-6.9%
0.00%0.0%
Q4 2013$1,096,000
+20.7%
47,672
+0.1%
0.00%0.0%
Q3 2013$908,000
+30.6%
47,638
-1.2%
0.00%0.0%
Q2 2013$695,00048,1990.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders